David J. Epstein

Infectious Disease

965 High St
Palo Alto, CA 94301

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Third-Degree Heart Block in COVID-19 Pneumonia Complicated by Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia. A Case Report and Review of Literature.

Third-Degree Heart Block in COVID-19 Pneumonia Complicated by Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia. A Case Report and Review of Literature.

Journal: Journal of community hospital internal medicine perspectives

Published: May 11, 2023

INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial.

INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial.

Journal: Retina (Philadelphia, Pa.)

Published: April 07, 2018

Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.

Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.

Journal: Ophthalmology

Published: March 12, 2012

Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.

Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.

Journal: Ophthalmology

Published: October 19, 2011

Showing 1-4 of 4

Last Updated: 09/26/2026